益钙宁治疗原发性骨质疏松性骨痛的疗效观察

Observation on effects of Elcitonin curing primarily osteoporotic osteodynia

目的 :探讨益钙宁对原发性骨质疏松性骨痛的疗效。方法 :对 30例原发性骨质疏松患者进行益钙宁治疗 ,并对治疗前后临床症状及体征进行观察、腰椎平片对比及治疗前后腰椎椎体BMD的QCT测量。结果 :益钙宁治疗原发性骨质疏松症骨痛的综合改善率为 93 3% ,其中单项症状及体征的改善率为 5 6 5 %～ 92 2 % ,症状及体征的改善先于骨量的变化。结论 :益钙宁对原发性骨质疏松症有显著疗效 ,但对增加骨量或延缓骨量减少的长期作用尚有待随访。

Objective:To explore the curative effects of Elcitonin in treating primarily osteoporotic osteodynia.Methods:Thirty patients with primary osteoporosis were cured with Eleitonin.In front and behind the treatment,the clinical symptoms and signs were observed,the wmbar x-Ray graphs were contrasted,and the QCT of lumber's BMD were measwred.Results:Multiple improvement rates of Elcitonin in treating primarily osteoporotic osteodynia is 93.3%,while the improrements in single symptom or sign is 56.5～92.2%.The improvement in symptom and sign is prior to the change in osseous quality.Conclusion:Elcitonin is remarkably effective in curing primary osteoporosis but the long-time potenay in creasing osseous quality or delaying the loss of osseous quality needs further exploration.